These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 4064909)
1. Prescribing methadone for the opiate addict: a problem of dosage conversion. Johns AR; Gossop M Drug Alcohol Depend; 1985 Sep; 16(1):61-6. PubMed ID: 4064909 [TBL] [Abstract][Full Text] [Related]
2. Patterns of opiate use in a heroin maintenance programme. Perneger TV; Mino A; Giner F; Broers B Psychopharmacology (Berl); 2000 Sep; 152(1):7-13. PubMed ID: 11041310 [TBL] [Abstract][Full Text] [Related]
3. Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005. Strang J; Manning V; Mayet S; Ridge G; Best D; Sheridan J Addiction; 2007 May; 102(5):761-70. PubMed ID: 17506153 [TBL] [Abstract][Full Text] [Related]
4. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT). Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885 [TBL] [Abstract][Full Text] [Related]
5. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study. Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805 [TBL] [Abstract][Full Text] [Related]
6. Injectable methadone prescribing in the United Kingdom--current practice and future policy guidelines. Sarfraz A; Alcorn RJ Subst Use Misuse; 1999 Oct; 34(12):1709-21. PubMed ID: 10499416 [TBL] [Abstract][Full Text] [Related]
7. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts. Hensel M; Kox WJ Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849 [TBL] [Abstract][Full Text] [Related]
8. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438 [TBL] [Abstract][Full Text] [Related]
9. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Curran HV; Kleckham J; Bearn J; Strang J; Wanigaratne S Psychopharmacology (Berl); 2001 Mar; 154(2):153-60. PubMed ID: 11314677 [TBL] [Abstract][Full Text] [Related]
10. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants. Giacomuzzi S; Kemmler G; Ertl M; Riemer Y Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744 [TBL] [Abstract][Full Text] [Related]
11. Carriage of Staphylococcus aureus among injection drug users: lower prevalence in an injection heroin maintenance program than in an oral methadone program. Bassetti S; Wolfisberg L; Jaussi B; Frei R; Kuntze MF; Battegay M; Widmer AF Infect Control Hosp Epidemiol; 2004 Feb; 25(2):133-7. PubMed ID: 14994939 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of L-methadone and racemic methadone in substitution treatment for opiate addicts--a double-blind comparison. Scherbaum N; Finkbeiner T; Leifert K; Gastpar M Pharmacopsychiatry; 1996 Nov; 29(6):212-5. PubMed ID: 8956350 [TBL] [Abstract][Full Text] [Related]
13. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China. Chen W; Li X; Li X; Ling L; Xia Y; Chen J; He Q J Addict Med; 2012 Sep; 6(3):212-8. PubMed ID: 22614937 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. Metrebian N; Shanahan W; Wells B; Stimson GV Med J Aust; 1998 Jun; 168(12):596-600. PubMed ID: 9673620 [TBL] [Abstract][Full Text] [Related]
15. Heroin anticraving medications: a systematic review. Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107 [TBL] [Abstract][Full Text] [Related]
16. Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility. Wolff K; Rostami-Hodjegan A; Hay AW; Raistrick D; Tucker G Addiction; 2000 Dec; 95(12):1771-83. PubMed ID: 11177493 [TBL] [Abstract][Full Text] [Related]
17. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786 [TBL] [Abstract][Full Text] [Related]
18. Illicit use of methadone in heroin addicts in Rome. Grassi MC; Nencini P; Paroli E Ann Ist Super Sanita; 1991; 27(4):671-4. PubMed ID: 1820739 [TBL] [Abstract][Full Text] [Related]
19. Methadone prescribing to opiate addicts by private doctors: comparison with NHS practice in south east England. Strang J; Sheridan J Addiction; 2001 Apr; 96(4):567-76. PubMed ID: 11300960 [TBL] [Abstract][Full Text] [Related]
20. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]